Holen Sie sich die Stockscreener-App
9.3192
0.27%
-0.0308
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$9.35
Offen:
$9.335
24-Stunden-Volumen:
2.63M
Relative Volume:
0.57
Marktkapitalisierung:
$1.53B
Einnahmen:
$596.34M
Nettoeinkommen (Verlust:
$-87.84M
KGV:
-15.60
EPS:
-0.5975
Netto-Cashflow:
$-97.62M
1W Leistung:
-1.01%
1M Leistung:
-1.74%
6M Leistung:
+22.37%
1J Leistung:
+41.07%
1-Tages-Spanne:
$8.885
$9.48
1-Wochen-Bereich:
$8.885
$10.12
52-Wochen-Spanne:
$6.20
$11.97
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
9.31 | 1.60B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
523.88 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.87 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
921.67 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.22 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.59 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance Singapore
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Does Novavax’s (NVAX) Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story? - simplywall.st
Novavax (NVAX) Stock Moves 1.36%: What You Should Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
(NVAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2500 Growth Benchmark - marketscreener.com
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Price to sales forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Price to sales forward of Novavax, Inc. – FWB:NVV1 - TradingView
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax boosts efficiency and productivity with ServiceNow - NTT Data
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Enterprise value to EBITDA forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Enterprise value to EBITDA forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Enterprise value to revenue forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Enterprise value to revenue forward of Novavax, Inc. – SIX:NVAX - TradingView
Price to sales forward of Novavax, Inc. – SIX:NVAX - TradingView
Enterprise value to EBIT forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax, Inc. Actuals & Estimates (SIX:NVAX) - TradingView
Price to book forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
These Stocks Are Moving the Most Today: Novavax, Palantir, Shoals, Plug Power, DaVita, and More - Barron's
NVAX Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD - Moomoo
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Shah Capital campaign falls short at Novavax despite opposition to board, pay - Alternatives Watch
Shah Capital blasts Novavax annual meeting results - The American Bazaar
Novavax faces renewed attack by Shah Capital after AGM - MSN
Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting - citybiz
Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval - GuruFocus
Novavax | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M - Moomoo
Novavax Shareholders Approve Directors, Pay and Incentive Plans - The Globe and Mail
Novavax targeted by Shah Capital after AGM (NVAX:NASDAQ) - Seeking Alpha
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM - Yahoo Finance
Form 4 Novavax Inc For: 23 June By Investing.com - Investing.com Australia
Novavax (NVAX) director gains RSU and option grants, exercises award - Stock Titan
Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J - Moomoo
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.18%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):